A technology developed at The University of Queensland allowing scientists to observe how disease-related proteins behave inside living neurons will be used to advance early drug discovery for neurodegenerative diseases. The NASTIC (Nanoscale Spatiotemporal Indexing Clustering) platform, spun out into Brisbane-based startup Accretion Bio, enables researchers to study real-time biological processes in living cells across space and time at the single-molecule level for the first time.
Nanoscale tech tracks proteins inside living neurons to guide Alzheimer's and Parkinson's drug discovery
Original Source
This article was collected from: Phys.org
Gabeshana News automatically collects article information
from external RSS/Atom sources. The original article remains
available at the source website. Please visit the original
source for the complete article and the latest information.